ATOSSA THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ATOSSA THERAPEUTICS, INC. (ATOS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.47M shares, a 7.76% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.64M shares, a 35.88% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 24.46M shares, a 41.45% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.67M shares, a 93.02% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.53M shares, a 42.63% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.67M shares, a 93.20% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 39.23M shares, a 99.89% decline from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 34.98B shares, a 104786.44% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.47M shares 10-Q · filed 2026-08-07 | 2.06M shares 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | 1.64M shares 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | 1.53M shares 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | 24.46M shares 10-Q · filed 2025-11-12 | 22.68M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 2.67M shares 10-Q · filed 2026-08-07 | 40.28M shares 10-Q · filed 2025-08-12 | 2.62M shares 10-Q · filed 2026-08-07 | 39.46M shares 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | 2.56M shares 10-Q · filed 2026-05-08 | 38.63M shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 2.67M shares 10-K · filed 2026-03-25 | 40.03M shares 10-K · filed 2025-03-25 | ||||||
| 2024-09-30 | 41.78M shares 10-Q · filed 2025-11-12 | 39.69M shares 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | 38.29M shares 10-Q · filed 2025-08-12 | 38.63M shares 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | 38.98M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 39.23M shares 10-K · filed 2025-03-25 | 39.23B shares 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | 42.27M shares 10-Q · filed 2024-11-12 | 42.27M shares 10-Q · filed 2023-11-13 | 39.42M shares 10-Q · filed 2024-11-12 | 39.42M shares 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 39.51M shares 10-Q · filed 2024-08-12 | 39.51M shares 10-Q · filed 2023-08-14 | 37.97M shares 10-Q · filed 2024-08-12 | 37.97M shares 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 36.42M shares 10-Q · filed 2024-05-13 | 36.42M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 34.98B shares 10-K · filed 2024-04-01 | 34.98M shares 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | 35.43M shares 10-Q · filed 2023-11-13 | 34.83M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 35.51M shares 10-Q · filed 2023-08-14 | 34.53M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 33.53M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 33.35M shares 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | 32.57M shares 10-Q · filed 2022-11-07 | 32.57M shares 10-Q · filed 2021-11-15 | 33.63M shares 10-Q · filed 2022-11-07 | 33.63M shares 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 36.00M shares 10-Q · filed 2022-08-08 | 36.00M shares 10-Q · filed 2021-08-13 | 34.17M shares 10-Q · filed 2022-08-08 | 34.17M shares 10-Q · filed 2021-08-13 | ||||
| 2021-03-31 | 32.32M shares 10-Q · filed 2022-05-09 | 32.32M shares 10-Q · filed 2021-05-14 | ||||||
| 2020-12-31 | 8.64M shares 10-K · filed 2021-03-31 | |||||||
| 2020-09-30 | 8.41M shares 10-Q · filed 2021-11-15 | 7.08M shares 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 7.25M shares 10-Q · filed 2021-08-13 | 6.41M shares 10-Q · filed 2021-08-13 | ||||||
| 2020-03-31 | 5.57M shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 4.91M shares 10-K · filed 2021-03-31 | |||||||
| 2019-09-30 | 5.61M shares 10-Q · filed 2020-11-13 | 4.68M shares 10-Q · filed 2020-11-13 | ||||||
| 2019-06-30 | 3.81M shares 10-Q · filed 2020-08-13 | 4.21M shares 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | 4.61M shares 10-Q · filed 2020-05-13 | |||||||
| 2018-12-31 | 4.32M shares 10-K · filed 2020-03-26 | |||||||
| 2018-09-30 | 6.84M shares 10-Q · filed 2018-11-14 | 3.78M shares 10-Q · filed 2019-11-13 | ||||||
| 2018-06-30 | 6.84M shares 10-Q · filed 2019-11-13 | 3.38M shares 10-Q · filed 2018-08-13 | 2.24M shares 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | 90.71K shares 10-Q · filed 2019-05-13 | 1.09M shares 10-Q · filed 2018-05-14 | ||||||
| 2017-12-31 | 375.20K shares 10-K · filed 2019-03-28 | |||||||
| 2017-09-30 | 357.35K shares 10-Q · filed 2018-11-14 | 4.29M shares 10-Q · filed 2017-11-13 | 402.38K shares 10-Q · filed 2018-11-14 | 4.83M shares 10-Q · filed 2017-11-13 | ||||
| 2017-06-30 | 787.14K shares 10-Q/A · filed 2018-11-13 | 9.45M shares 10-Q · filed 2017-08-14 | 428.26K shares 10-Q/A · filed 2018-11-13 | 5.14M shares 10-Q · filed 2017-08-14 | ||||
| 2017-06-23 | 787.14K shares 10-Q · filed 2018-08-13 | |||||||
| 2017-03-31 | 63.66K shares 10-Q · filed 2018-05-14 | 782.99K shares 10-Q · filed 2017-05-11 | ||||||
| 2016-12-31 | 781.15K shares 10-K/A · filed 2017-03-21 | |||||||
| 2016-09-30 | 792.65K shares 10-Q · filed 2017-11-13 | 816.40K shares 10-Q · filed 2016-11-14 | 792.65K shares 10-Q · filed 2017-11-13 | 816.40K shares 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | 796.32K shares 10-Q · filed 2017-08-14 | 11.94M shares 10-Q · filed 2016-08-12 | 796.32K shares 10-Q · filed 2017-08-14 | 11.94M shares 10-Q · filed 2016-08-12 | ||||
| 2016-03-31 | 615.68K shares 10-Q · filed 2017-05-11 | 9.24M shares 10-Q · filed 2016-05-05 | ||||||
| 2015-12-31 | 643.16K shares 10-K/A · filed 2017-03-21 | 9.65M shares 10-K · filed 2016-03-30 | ||||||
| 2015-09-30 | 930.46K shares 10-Q/A · filed 2017-03-21 | 12.65M shares 10-Q · filed 2015-11-12 | 930.46K shares 10-Q/A · filed 2017-03-21 | 12.65M shares 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | 13.96M shares 10-Q/A · filed 2017-03-21 | 13.96M shares 10-Q/A · filed 2017-03-21 | ||||||
| 2015-03-31 | 10.39M shares 10-Q/A · filed 2017-03-21 | |||||||
| 2014-12-31 | 9.71M shares 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | 9.50M shares 10-Q · filed 2015-11-12 | 9.50M shares 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | 9.64M shares 10-Q · filed 2015-08-06 | 94.92K shares 10-Q · filed 2014-08-12 | 9.64M shares 10-Q · filed 2015-08-06 | 94.92K shares 10-Q · filed 2014-08-12 | ||||
| 2014-03-31 | 7.02M shares 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | 7.03M shares 10-K · filed 2015-03-30 | |||||||
| 2013-09-30 | 7.02M shares 10-Q · filed 2014-11-12 | 9.50M shares 10-Q · filed 2014-11-12 | ||||||
| 2013-06-30 | 13.88K shares 10-Q · filed 2014-08-12 | 195.98K shares 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |